Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.

Journal article

Forouhan M. et al, (2022), Acta Neuropathol

Nuclear microRNA-466c regulates Vegfa expression in response to hypoxia

Journal article

Laitinen P. et al, (2022), PLoS ONE, 17

Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology


Martin Perez C. et al, (2022), Methods in Molecular Biology, 2383, 119 - 141

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.

Journal article

Hanson B. et al, (2021), RNA Biol, 1 - 15

Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Journal article

Marsh S. et al, (2020), Mol Ther, 28, 2527 - 2539

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.

Journal article

van Westering TLE. et al, (2020), Mol Cell Proteomics, 19, 2047 - 2068

Advances in oligonucleotide drug delivery.

Journal article

Roberts TC. et al, (2020), Nat Rev Drug Discov, 19, 673 - 694

Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology.

Journal article

van Westering TLE. et al, (2020), J Cachexia Sarcopenia Muscle, 11, 578 - 593

Load More